Larch Arabinogalactan for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Larch Arabinogalactan for Health & Longevity

Created on 07/21/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

A well-tolerated soluble fiber from larch wood that feeds gut bacteria and gently supports immunity. The strongest human findings: a stronger antibody response after certain vaccines and modestly fewer colds, plus favorable gut bacteria shifts. Benefits for blood fats, sugar, brain, and aging remain unproven. Low-risk and low-cost, with mild gas the main downside. (Full Review)

Protocol

Standard Dose
1.5–4.5 g/day
Standardized ResistAid extract or generic powder; microbiome studies used up to 15 g/day
Immune-Focused Dose
4.5 g/day
Most studied dose for cold resistance and vaccine response; 1.5 g/day sufficient for the tetanus antibody effect
Dosing Pattern
Single or split daily
Splitting into two servings reduces gas at higher intakes; any time of day, with or without food
Time to effect
Immune Outcomes
6–12 weeks
Trial window over which fewer colds and stronger vaccine antibody responses were measured
Microbiome Shift
Several weeks
Prebiotic and gut bacteria changes develop gradually rather than in days
Evaluation Window
8–12 weeks
Realistic period to judge benefit before deciding whether to continue

Benefits

Contraindications
  • Solid-organ transplant recipients or others on immunosuppression
  • Active autoimmune disease
  • Known larch or tree hypersensitivity
  • Pregnancy or breastfeeding
    •
Key Interactions
  • Immunosuppressant drugs (cyclosporine, tacrolimus, prednisone)
  • Immune-modulating and biologic therapies
  • Oral medications, iron, and minerals (separate dosing by ~2 hours)
  • Immune-stimulating supplements (Echinacea, beta-glucans, medicinal mushroom extracts)
  • Prebiotic fibers and probiotics (inulin, fructo-oligosaccharides)
    •

Risk & Side Effects

  • High:
  • Medium: Gastrointestinal discomfort
    •
  • Low: Allergic and hypersensitivity reactions, theoretical aggravation of autoimmune activity
    •
  • Speculative: Reduced efficacy of immunosuppressant therapy, caution in advanced kidney or liver disease
    •

Monitoring

Marker Target Why
hs-CRP < 1.0 mg/L Tracks systemic inflammation the fiber may modestly influence
Fasting glucose 75–90 mg/dL Screens for any metabolic effect of a soluble fiber
Fasting lipid panel LDL < 100 mg/dL; triglycerides < 90 mg/dL Detects any lipid change from soluble fiber
CBC with differential Within lab reference range Provides a general immune-cell snapshot for those tracking immune goals

Cadence: Optional; baseline, then at roughly 3 months, and thereafter every 6–12 months

Qualitative Assessment

  • Infection frequency and severity: number and duration of colds or respiratory infections across a season
  • Digestive comfort: bloating, gas, cramping, and overall gut comfort, especially during titration
  • Bowel regularity: stool frequency and consistency as the added soluble fiber takes effect
  • Energy and general well-being: subjective vitality and resilience during periods of stress or seasonal illness
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.